Once-daily glatiramer acetate decreases magnetic resonance imaging disease activity in Japanese patients with relapsing-remitting multiple sclerosis.
Clinical & experimental neuroimmunology（2017）
摘要
The present study confirmed the well-established safety, tolerability and efficacy profile of GA in Japanese MS patients.
更多查看译文
关键词
Japanese,T2 lesions,gadolinium‐enhancing lesions,glatiramer acetate,relapsing–remitting multiple sclerosis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要